ABBV
AbbVie Inc.
- Diluted EPS, 2025
- $2.36
- YoY, 2025
- −1.3%
- 5-year CAGR
- −2.8%
- 10-year CAGR
- −2.8%
Diluted EPS
Diluted EPS by fiscal year
| Period | EPS | YoY |
|---|---|---|
| 2025 | $2.36 | −1.3% |
| 2024 | $2.39 | −12.1% |
| 2023 | $2.72 | −59.0% |
| 2022 | $6.63 | +2.8% |
| 2021 | $6.45 | +137.1% |
| 2020 | $2.72 | −48.5% |
| 2019 | $5.28 | +44.3% |
| 2018 | $3.66 | +10.9% |
| 2017 | $3.30 | −9.1% |
| 2016 | $3.63 | +16.0% |
| 2015 | $3.13 | +184.5% |
| 2014 | $1.10 | −57.0% |
| 2013 | $2.56 | −23.6% |
| 2012 | $3.35 | +53.7% |
| 2011 | $2.18 | — |